4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001237334-26-000002
Director sold 1,000 shares at $510.00 ($510,000)
- Director acquired 1,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CAUSEY CHRISTOPHER Director | 2026-01-06 | Option exercise 10b5-1 | +1,000 | $119.76 | $119,760 | 5,190 | D: show line 1 in the form |
| CAUSEY CHRISTOPHER Director | 2026-01-06 | Sale 10b5-1 | −1,000 | $510.00 | $510,000 | 4,190 | D: show line 2 in the form |
| Open-market sales · 1,000 sh · avg $510.00 · $510,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CAUSEY CHRISTOPHER Director | 2026-01-06 | Option exercise · Stock Option 10b5-1 | −1,000 | 7,320 | D: show line 3 in the form |
Loading xslF345X05/primarydocument.xml…